- Home
- CCM vs COCP Comparison
CCM vs COCP Comparison
Compare CCM & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCM
- COCP
- Stock Information
- Founded
- CCM 1997
- COCP N/A
- Country
- CCM China
- COCP United States
- Employees
- CCM N/A
- COCP N/A
- Industry
- CCM Medical/Nursing Services
- COCP Biotechnology: Pharmaceutical Preparations
- Sector
- CCM Health Care
- COCP Health Care
- Exchange
- CCM Nasdaq
- COCP Nasdaq
- Market Cap
- CCM 18.2M
- COCP 15.3M
- IPO Year
- CCM 2009
- COCP N/A
- Fundamental
- Price
- CCM $4.13
- COCP $1.43
- Analyst Decision
- CCM
- COCP Strong Buy
- Analyst Count
- CCM 0
- COCP 1
- Target Price
- CCM N/A
- COCP $7.00
- AVG Volume (30 Days)
- CCM 9.6K
- COCP 17.0K
- Earning Date
- CCM 04-21-2025
- COCP 03-31-2025
- Dividend Yield
- CCM N/A
- COCP N/A
- EPS Growth
- CCM N/A
- COCP N/A
- EPS
- CCM N/A
- COCP N/A
- Revenue
- CCM $64,910,622.00
- COCP N/A
- Revenue This Year
- CCM N/A
- COCP N/A
- Revenue Next Year
- CCM N/A
- COCP N/A
- P/E Ratio
- CCM N/A
- COCP N/A
- Revenue Growth
- CCM N/A
- COCP N/A
- 52 Week Low
- CCM $3.80
- COCP $1.35
- 52 Week High
- CCM $26.70
- COCP $3.26
- Technical
- Relative Strength Index (RSI)
- CCM 45.62
- COCP 34.72
- Support Level
- CCM $3.90
- COCP $1.38
- Resistance Level
- CCM $4.40
- COCP $1.49
- Average True Range (ATR)
- CCM 0.42
- COCP 0.10
- MACD
- CCM 0.02
- COCP -0.00
- Stochastic Oscillator
- CCM 30.84
- COCP 12.82
About CCM Concord Medical Services Holdings Limited
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company operates cooperative centers across several provinces and administrative regions in China. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services, such as electroencephalography for the diagnosis of epilepsy, thermotherapy to increase the efficacy of and for pain relief after radiotherapy and chemotherapy, high-intensity focused ultrasound therapy for the treatment of cancer, stereotactic radiofrequency ablation for the treatment of Parkinson's Disease and refraction and tonometry for the diagnosis of ophthalmic conditions.
About COCP Cocrystal Pharma Inc.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first- and-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).